Brief: Tianjin Development Says Qtrly Net Profit Attributable Of Tianjin Lisheng Pharmaceutical Co RMB42 Mln
April 27 (Reuters) - Tianjin Lisheng Pharmaceutical Co Ltd
002393.SZ :
* QTRLY NET PROFIT ATTRIBUTABLE OF TIANJIN LISHENG
PHARMACEUTICAL
CO RMB42 MILLION VERSUS RMB36.1 MILLION
* QTRLY TOTAL OPERATING INCOME FOR TIANJIN LISHENG
PHARMACEUTICAL
RMB306.5 MILLION VERSUS RMB 327.6 MILLION
Source text for Eikon: ID:nHKS5W9GYN
Further company coverage: 002393.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln